Harbor Capital Advisors, Inc. Repare Therapeutics Inc. Transaction History

Harbor Capital Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.53 - $8.41 $57,096 - $105,999	12,604 Added 26.23%	60,659 $286,000
Q4 2023 Jan 08, 2024	BUY	$3.22 - $11.79 $19,223 - $70,386	5,970 Added 14.19%	48,055 $350,000
Q3 2023 Oct 20, 2023	BUY	$8.16 - $13.01 $41,624 - $66,364	5,101 Added 13.79%	42,085 $508,000
Q2 2023 Jul 11, 2023	BUY	$8.63 - $12.53 $29,083 - $42,226	3,370 Added 10.03%	36,984 $391,000
Q1 2023 Apr 26, 2023	SELL	$9.32 - $15.06 $8,928 - $14,427	-958 Reduced 2.77%	33,614 $330,000
Q4 2022 Jan 20, 2023	BUY	$12.5 - $18.13 $432,150 - $626,790	34,572 New	34,572 $0

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $56.6M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.